1. Home
  2. LAC vs BCYC Comparison

LAC vs BCYC Comparison

Compare LAC & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAC
  • BCYC
  • Stock Information
  • Founded
  • LAC 2023
  • BCYC 2009
  • Country
  • LAC Canada
  • BCYC United Kingdom
  • Employees
  • LAC N/A
  • BCYC N/A
  • Industry
  • LAC Metal Mining
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LAC Basic Materials
  • BCYC Health Care
  • Exchange
  • LAC Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • LAC 636.4M
  • BCYC 581.7M
  • IPO Year
  • LAC N/A
  • BCYC 2019
  • Fundamental
  • Price
  • LAC $3.16
  • BCYC $8.34
  • Analyst Decision
  • LAC Hold
  • BCYC Buy
  • Analyst Count
  • LAC 6
  • BCYC 10
  • Target Price
  • LAC $4.29
  • BCYC $25.00
  • AVG Volume (30 Days)
  • LAC 3.8M
  • BCYC 401.9K
  • Earning Date
  • LAC 05-20-2025
  • BCYC 05-01-2025
  • Dividend Yield
  • LAC N/A
  • BCYC N/A
  • EPS Growth
  • LAC N/A
  • BCYC N/A
  • EPS
  • LAC N/A
  • BCYC N/A
  • Revenue
  • LAC N/A
  • BCYC $25,722,000.00
  • Revenue This Year
  • LAC N/A
  • BCYC N/A
  • Revenue Next Year
  • LAC N/A
  • BCYC $0.27
  • P/E Ratio
  • LAC N/A
  • BCYC N/A
  • Revenue Growth
  • LAC N/A
  • BCYC N/A
  • 52 Week Low
  • LAC $2.02
  • BCYC $6.10
  • 52 Week High
  • LAC $5.20
  • BCYC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • LAC 64.96
  • BCYC 49.88
  • Support Level
  • LAC $2.89
  • BCYC $7.95
  • Resistance Level
  • LAC $3.03
  • BCYC $9.55
  • Average True Range (ATR)
  • LAC 0.13
  • BCYC 0.72
  • MACD
  • LAC 0.04
  • BCYC 0.05
  • Stochastic Oscillator
  • LAC 81.98
  • BCYC 43.98

About LAC Lithium Americas Corp.

Lithium Americas is a pure-play lithium producer. The firm owns 62% of one resource, Thacker Pass, that is located in northwest Nevada, with automaker General Motors owning the remaining 38%. Thacker Pass recently began construction and is expected to begin production in the mid- to late 2020s. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: